// App-Quantinova.ai

134 : A Double Heterozygote for LCAT and ABCA1 Mutations Accounts for Severe Hypoalphalipoproteinemia

Researchers

Presenter

  • Adam McIntyre

Principal Investigators

  • Robert A Hegele

Medical Centers

  • The Medical College of Wisconsin, Milwaukee, WI

  • University of Western Ontario, London, ON, Canada

Locations

  • United States

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Hypoalphalipoproteinemia

  • Coronary Artery Disease

  • Dyslipidemia

Biomarkers

  • E-selectin

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim